Bortezomib-Containing Regimens for the Treatment of Newly Diagnosed AL Amyloidosis: Experience of Two Centers in Canada

被引：1

作者：

Alahwal, Hatem ^{[1
]}

Song, Kevin W. ^{[2
]}

Duggan, Peter ^{[3
]}

Sutherland, Heather J. ^{[4
]}

Neri, Paola ^{[5
]}

Broady, Raewyn ^{[6
]}

Bahlis, Nizar J. ^{[5
,7
]}

Jimenez-Zepeda, Victor ^{[3
]}

机构：

[1] British Columbia Canc Agcy, Vancouver, BC, Canada

[2] Univ British Columbia, Div Hematol & Leukemia, BMT Program BC, Vancouver, BC, Canada

[3] Tom Baker Canc Clin, Dept Med Oncol & Hematol, Calgary, AB, Canada

[4] BCCA, Vancouver, BC, Canada

[5] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada

[6] Univ British Columbia, Div Hematol, Leukemia BMT Program BC, Vancouver, BC, Canada

[7] Univ Calgary, Calgary, AB, Canada

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.2131.2131

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2131

引用

页数：5

共 50 条

[1] Comparison of three bortezomib-containing regimens for the treatment of newly diagnosed AL amyloidosis
Zepeda, Victor Jimenez
Prefontaine, Amiee
McCulloch, Sylvia
Lewis, Ellen
Tay, Jason
Duggan, Peter
Neri, Paola
Bahlis, Nizar
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S122 - S123
[2] Bortezomib-Containing Regimens for the Treatment of Newly Diagnosed and Relapsed Amyloid Light Chain Amyloidosis: A Single-Center Experience
Jimenez-Zepeda, Victor H.
Duggan, Peter
Neri, Paola
Bahlis, Nizar J.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (06): : E79 - E84
[3] Effect of the Presence of t(11;14) for Patients With AL Amyloidosis Treated With Bortezomib-Containing Regimens: Experience From the Amyloidosis Program of Calgary
Lewis, Ellen
McCulloch, Sylvia
Mahe, Etienne
Bahlis, Nizar
Neri, Paola
Tay, Jason
Duggan, Peter
Jimenez-Zepeda, Victor H.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (10): : E331 - E334
[4] Doxycycline Plus Bortezomib-Containing Regimens for the Treatment of Light-Chain Amyloidosis in the Frontline Setting: Experience from the Amyloidosis Program of Calgary
Lewis, Ellen
Fine, Nowell
Mcculloch, Sylvia
Tay, Jason
Duggan, Peter
Neri, Paola
Bahlis, Nizar
Jimenez-Zepeda, Victor H.
CURRENT ONCOLOGY, 2024, 31 (09) : 5608 - 5616
[5] Efficacy and Safety Profile of Bortezomib Based Regimens for Treatment of Newly Diagnosed Amyloidosis: A Systematic Review of Literature
Yousaf, Muhammad Abdullah
Ahmad, Muhaddis Ejaz
Yusufi, Maaz Ahmed
Hassan, Hamza
Mushtaq, Adeela
Iftikhar, Ahmad
Malik, Mustafa Nadeem
Rafae, Abdul
Shah, Zunairah
Ibrahim, Ahmed
Basheer, Adnan
Anwer, Faiz
BLOOD, 2019, 134
[6] Bortezomib Containing Regimens Are Highly Effective for Systemic AL Amyloidosis: Experience from a Single Center
Zepeda, Victor H. Jimenez
Duggan, Peter
Neri, Paola E.
Bahlis, Nizar J.
BLOOD, 2014, 124 (21)
[7] THE EFFICACY OF BORTEZOMIB AND BORTEZOMIB-CONTAINING REGIMENS FOR TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL CLINICAL PRACTICE
Mitina, T.
Golenkov, A.
Kataeva, E.
Lutskaya, T.
Trifonova, E.
Klinushkina, E.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 576 - 576
[8] Bortezomib-containing regimens (BCR) for the treatment of non-transplant eligible multiple myeloma
Jimenez-Zepeda, Victor H.
Duggan, Peter
Neri, Paola
Tay, Jason
Bahlis, Nizar J.
ANNALS OF HEMATOLOGY, 2017, 96 (03) : 431 - 439
[9] Bortezomib-Containing Regimens (BCR) for the Treatment of Non-Transplant Eligible Multiple Myeloma
Jimenez-Zepeda, Victor H.
Duggan, Peter
Neri, Paola
Bahlis, Nizar J.
BLOOD, 2015, 126 (23)
[10] Efficacy of Bortezomib-Based Regimens for Patients with Newly Diagnosed AL Amyloidosis Not Receiving ASCT Compared with Alkylators and Dexamethasone-Based Regimens
Lim, Sung Won
Park, Song Ee
Cho, Jangho
Kim, Youjin
Lee, Hansang
Hong, Juhyun
Jeon, Eunseok
Choi, Jinoh
Lee, Gayeon
Kim, Byungjun
Min, Ju Hong
Kim, Jung Sun
Lee, Jung Eun
Choi, Joon Young
Park, Silvia
Kim, Seok Jin
Jang, Jun Ho
Kim, Won Seog
Jung, Chul Won
Kim, Kihyun
BLOOD, 2017, 130

← 1 2 3 4 5 →